TIMMA-R: an R package for predicting synergistic multi-targeted drug combinations in cancer cell lines or patient-derived samples

Research output: Contribution to journalJournal articleResearchpeer-review

UNLABELLED: Network pharmacology-based prediction of multi-targeted drug combinations is becoming a promising strategy to improve anticancer efficacy and safety. We developed a logic-based network algorithm, called Target Inhibition Interaction using Maximization and Minimization Averaging (TIMMA), which predicts the effects of drug combinations based on their binary drug-target interactions and single-drug sensitivity profiles in a given cancer sample. Here, we report the R implementation of the algorithm (TIMMA-R), which is much faster than the original MATLAB code. The major extensions include modeling of multiclass drug-target profiles and network visualization. We also show that the TIMMA-R predictions are robust to the intrinsic noise in the experimental data, thus making it a promising high-throughput tool to prioritize drug combinations in various cancer types for follow-up experimentation or clinical applications.

AVAILABILITY AND IMPLEMENTATION: TIMMA-R source code is freely available at http://cran.r-project.org/web/packages/timma/.

Original languageEnglish
JournalBioinformatics (Online)
Volume31
Issue number11
Pages (from-to)1866-8
Number of pages3
ISSN1367-4811
DOIs
Publication statusPublished - 1 Jun 2015
Externally publishedYes

    Research areas

  • Algorithms, Antineoplastic Combined Chemotherapy Protocols/pharmacology, Cell Line, Tumor, Drug Discovery, Drug Synergism, Humans, Neoplasms/drug therapy, Software

ID: 199429384